Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leishmaniasis, Mucocutaneous”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Large-scale testing (Phase 3)Study completedNCT03829917
What this trial is testing

Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis

Who this might be right for
Cutaneous Leishmaniasis, American
Fundacion Nacional de Dermatologia 120
Not applicableLooking for participantsNCT07504757
What this trial is testing

LEISH-PED: Study on Leishmaniasis in Children

Who this might be right for
Leishmania Infantum DiseaseLeishmaniasis, VisceralLeishmaniasis, Cutaneous+1 more
Meyer Children's Hospital IRCCS 200
Large-scale testing (Phase 3)UnknownNCT04799236
What this trial is testing

Treatment of Mucosal Bolivian Leishmaniasis

Who this might be right for
Mucosal Leishmaniasis
Fundacion Nacional de Dermatologia 120
Testing effectiveness (Phase 2)Study completedNCT01377974
What this trial is testing

Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis

Who this might be right for
LeishmaniasisLeishmaniasis, Mucocutaneous
Brasilia University Hospital 40
Large-scale testing (Phase 3)UnknownNCT06040489
What this trial is testing

Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly

Who this might be right for
Leishmaniasis; BrazilianLeishmaniasis, Mucocutaneous
University of Brasilia 100
Large-scale testing (Phase 3)UnknownNCT06011343
What this trial is testing

Tofacitinib Associated With Meglumine Antimoniate in Cutaneous Leishmaniasis

Who this might be right for
Cutaneous Leishmaniasis, American
Hospital Universitário Professor Edgard Santos 22
Large-scale testing (Phase 3)UnknownNCT01301937
What this trial is testing

Low Antimonial Dosage in American Mucosal Leishmaniasis

Who this might be right for
Mucosal LeishmaniasisMucocutaneous Leishmaniasis
Oswaldo Cruz Foundation 76
Testing effectiveness (Phase 2)UnknownNCT02530697
What this trial is testing

The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil

Who this might be right for
Leishmaniasis
University of Brasilia 160
Testing effectiveness (Phase 2)Study completedNCT06449040
What this trial is testing

Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the Elderly

Who this might be right for
Cutaneous Leishmaniasis, American
Hospital Universitário Professor Edgard Santos 28
Not applicableStudy completedNCT02431429
What this trial is testing

Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis

Who this might be right for
Mucocutaneous Leishmaniasis
Knight Therapeutics (USA) Inc 55
Testing effectiveness (Phase 2)UnknownNCT03084952
What this trial is testing

Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients

Who this might be right for
Leishmaniasis; American, CutaneousDrug Side Effect
Infan Industria Quimica Farmaceutica Nacional 52
Testing effectiveness (Phase 2)Study completedNCT06000514
What this trial is testing

Topical Sm29 in Combination With Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis.

Who this might be right for
Cutaneous Leishmaniasis, American
Hospital Universitário Professor Edgard Santos 20
Not applicableLooking for participantsNCT00344188
What this trial is testing

Diagnosis and Treatment of Leishmania Infections

Who this might be right for
KinetoplastidSkin Diseases, ParasiticParasitic Diseases+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 289
Testing effectiveness (Phase 2)Study completedNCT03294161
What this trial is testing

Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis

Who this might be right for
LeishmaniasisLeishmaniasis, CutaneousLeishmaniasis; American
Hospital Universitário Professor Edgard Santos 50
Early research (Phase 1)Not Yet RecruitingNCT07149753
What this trial is testing

Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous Leishmaniasis

Who this might be right for
Cutaneous LeishmaniasisCutaneous Leishmaniasis, AmericanTopical Administration
Universidad Industrial de Santander 15
Not applicableNo Longer AvailableNCT00508963
What this trial is testing

Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis

Who this might be right for
Leishmaniasis, CutaneousLeishmaniasis, Mucocutaneous
University of California, San Francisco
Large-scale testing (Phase 3)Study completedNCT03096457
What this trial is testing

Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia

Who this might be right for
Leishmaniasis, CutaneousLeishmania Braziliensis ComplexLeishmaniasis, American+1 more
Fundacion Nacional de Dermatologia 80
Not applicableStudy completedNCT05533736
What this trial is testing

Feasibility and Usability of Mobile Applications for Monitoring Cutaneous Leishmaniasis Treatment in Colombia

Who this might be right for
Cutaneous Leishmaniasis, American
Centro Internacional de Entrenamiento e Investigaciones Médicas 105
Testing effectiveness (Phase 2)Study completedNCT00373776
What this trial is testing

Miltefosine for Mucosal Leishmaniasis

Who this might be right for
Leishmaniasis
AB Foundation 75
Not applicableStudy completedNCT02429518
What this trial is testing

Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis

Who this might be right for
Mucocutaneous Leishmaniasis
Knight Therapeutics (USA) Inc 42
Next Page